COVID-19 Vaccine Development

A SARS-CoV-2 vaccine would be a very powerful tool to slow down the COVID-19 pandemic. Well over a hundred vaccine candidates are in development, with some already being tested for safety and efficacy, or in phase I clinical trials. This feed follows the latest studies on vaccine design and development.

July 24, 2020
Open Access

Designing Pull Funding For A COVID-19 Vaccine

Health Affairs
Christopher M SnyderJames Robinson
July 23, 2020
Preprint
Open Access

SARS-CoV-2-induced humoral immunity through B cell epitope analysis and neutralizing activity in COVID-19 infected individuals in Japan

BioRxiv : the Preprint Server for Biology
S. YoshidaHironori Nakagami
July 31, 2020
Preprint

New Pathways of Mutational Change in SARS-CoV-2 Proteomes Involve Regions of Intrinsic Disorder Important for Virus Replication and Release

BioRxiv : the Preprint Server for Biology
T. TomaszewskiGustavo Caetano-Anolles
July 28, 2020
Review
Open Access

COVID-19: Mechanisms of Vaccination and Immunity

Vaccines
Daniel E Speiser, Martin F Bachmann
July 23, 2020
Open Access

Social media and vaccine hesitancy: new updates for the era of COVID-19 and globalized infectious diseases

Human Vaccines & Immunotherapeutics
Neha PuriKeith Gunaratne
July 22, 2020
Open Access

An alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates

Science Translational Medicine
Jesse H ErasmusDeborah Heydenburg Fuller
August 2, 2020

A thermostable, closed SARS-CoV-2 spike protein trimer

Nature Structural & Molecular Biology
Xiaoli XiongJohn A G Briggs
July 26, 2020
Preprint
Open Access

Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as vaccine candidate

BioRxiv : the Preprint Server for Biology
W. SunPeter Palese
July 24, 2020
Preprint
Open Access

D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization.

MedRxiv : the Preprint Server for Health Sciences
Drew WeissmanD. C. Montefiori
July 24, 2020
Preprint
Open Access

Immuno-informatics approach for multi-epitope vaccine designing against SARS-CoV-2

BioRxiv : the Preprint Server for Biology
Souvik BanerjeeB. Mittal
July 30, 2020

Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates

The New England Journal of Medicine
Kizzmekia S CorbettBarney S Graham
July 24, 2020
Open Access

YouTube coverage of COVID-19 vaccine development: implications for awareness and uptake

Human Vaccines & Immunotherapeutics
Corey H BaschCharles E Basch
July 30, 2020
Open Access

A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity

Nature
Jingyun YangXiawei Wei
July 28, 2020
Review
Open Access

Lessons for COVID-19 Immunity from Other Coronavirus Infections

Immunity
Alan Sariol, Stanley Perlman

Sign up to follow this feed and discover related papers.

Related Feeds

AI-driven COVID-19 Management

Artificial intelligence (AI) offers a powerful new tool that could potentially be instrumental in controling and managing the SARS-CoV-2 virus. The papers in this feed report on the applications of AI to the current pandemic, which may be able to predict the location of the next outbreak, or facilitate new drug design.

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

COVID-19 Clinical Diagnosis

COVID-19 patients typically present with high fever and a persistent cough. This feed focuses on clinical diagnosis, including RT-PCR testing for the presence of SARS-CoV-2 and radiographic assessment of lungs.

COVID-19 Clinical Management

While most COVID-19 infections cause only mild to moderate symptoms, severely affected patients, such as those presenting with pneumonia, ARDS or septic shock, require hospitalization. This feed focuses on clinical management of patients using oxygen therapy, ventilation, and other treatment strategies, and covers some medical case reports.

COVID-19 Comorbidities

COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes, hypertension, cardiovascular disease, and chronic lung disease. Research into the intersection between comorbidities and COVID-19 is focusing on risks and treatment outcomes for these patients.

COVID-19 Complications

A growing number of complications associated with COVID-19 has been identified. This feed focuses primarily on cardiovascular and respiratory manifestations in severely ill patients.

COVID-19 Covalescent Plasma Therapy

Convalescent plasma therapy, where passive polyclonal antibody obtained from recovered patients are used to provide immediate immunity, has been tested in respiratory infections such as the 2009-2010 H1N1 influenza virus pandemic and the 2003 SARS-CoV-1 epidemic. This feed follows ongoing research efforts and clinical trials exploring covalescent plasma therapy as a potential treatment strategy for COVID-19.

COVID-19 Epidemiology and Demography

Epidemiological studies play a crucial role in understanding and managing the progression of COVID-19. Research followed in this feed includes studies of transmission dynamics and the change of the basic reproductive number (R) as new pubic health measures take effect.

COVID-19 Immune Response

Understanding the innate and acquired immune response to SARS-CoV-2 is essential for development of COVID-19 therapeutic treatment and design of prophylactic vaccines. This feed surfaces immunological studies, including studies into the cytokine storm that has been observed in severely ill patients.

COVID-19 Immunopathology

The research highlighted in this feed investigates the immunopathology seen in severely ill COVID-19 patients, which often resembles the cytokine storm syndrome: uncontrolled immune activation generates excessive release of cytokines, resulting in hyperinflammation and multi-organ disease.

© 2020 Meta ULC. All rights reserved
/feed-previews/covid-19-vaccine-development/6282cef3-6d29-4262-ad8a-a937a12a89f9